Torbugesic

• • Aids in the relief of pain associated with equine colic.
  • Preclinical model studies and clinical field trials in horses demonstrate that analgesic effects are seen within 15 minutes following injection and persist for approximately four hours.
  • Original synthetic, centrally acting, narcotic agonist-antagonist analgesic with potent antitussive activity.
  • Butorphanol has been demonstrated to be four times more potent than morphine.
  • Unlike classic narcotic agonist analgesics – which are associated with decreases in blood pressure, reduction in heart rate and concomitant release of histamine – butorphanol does not cause histamine release.  TORBUGESIC  TORBUGESIC  TORBUGESIC TORBUGESIC
  • The cardiopulmonary effects of butorphanol are not distinctly dosage-related but reach a ceiling effect beyond which further dosage increases resulting in relatively lesser side effects.

  Torbugesic Dosage

• • Administer 5 mL of TORBUGESIC injection for each 1,000 pounds of body weight by intravenous injection.
    • This is equivalent to 0.1 mg of butorphanol per kilogram of body weight (0.05 mg/lb.).
  • The dose may be repeated within three to four hours but treatment should not exceed 48 hours.

   

  Packaging of TORBUGESIC injection
  

  • 50-mL vial

IMPORTANT SAFETY INFORMATION 

Use TORBUGESIC with caution with other sedative or analgesic drugs as these are likely to produce additive effects. Do not use in breeding horses, weanlings, or foals. Do not use in horses intended for human consumption

Torbugesic injection

Home